Vanda Pharmaceuticals Inc announced that a HETLIOZ patent, number 10,071,977 (‘977 patent), is now listed in the U.S. Food and Drug Administration publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book. The ‘977 patent was issued by the United States Patent and Trademark Office on September 11, 2018 and expires in February 2035. Prior to this newly listed ‘977 patent, the HETLIOZ Orange Book listed patent with the latest expiry date was set to expire in May 2034.
How Benzos Act on Receptors in the Brain
September 22, 2020
TMJ & Airway Cadaver Course by Nierman Practice Management
Nierman Practice Management Training Center
Sleep and Wellness Conference 2023
Hilton Scottsdale Resort & Villas
Fairmont San Francisco
Sleep Professionals of Alabama Annual Conference
Perdido Beach Resort
No event found!
Powered by Modern Events Calendar